Search Results 471-480 of 17815 for Coagulate

  1. Gastroenterology and Hepatology - Clinical trials

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  2. Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (the "Apact" Study) - Mayo Clinic

    Acceptable coagulation studies as demonstrated by Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) within normal limits (±15%). Exclusion Criteria ...

  3. Conjugated estrogens (vaginal route) - Mayo Clinic

    Conjugated estrogens vaginal cream is used to treat changes in and around the vagina (such as vaginal dryness, itching, and burning) caused by low estrogen ...

  4. Publications - Indravadan J. Patel, M.D. - Mayo Clinic

    Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv ...

  5. Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant - Mayo Clinic

    History of clinically significant bleeding or known platelet or coagulation disorder; Clinically significant cardiac illness including New York Heart ...

  6. Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study - Mayo Clinic

    Coagulation disorders (platelets < 100,000, PT > 2 seconds above control or INR > 1.5); Anemia (Hemoglobin <11.0 g/dL in women and <12.5 g/dL in men); Liver ...

  7. Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions - Mayo Clinic

    Severely abnormal coagulation (INR>1.5); Patients with unstable cardiac status including: Unstable angina pectoris on medication; Patients with documented ...

  8. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

    Uncontrolled intercurrent illness including but not limited to uncontrolled infection, disseminated intravascular coagulation, or psychiatric illness/social ...

  9. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

    Coagulation: INR or PT and aPTT ≤ 1.5 × ULN unless participant is receiving anticoagulant therapy as long as PT or aPTT is within therapeutic range of ...

  10. Publications - Diana J. Kelm, M.D. - Mayo Clinic

    Predictors of Disseminated Intravascular Coagulation in Patients with Septic Shock. ISRN Critical Care. 2013; 2013(Article 219048):6. Kelm DJ, Torres KM ...